Geiger Markus, Wrulich Oliver A, Jenny Marcel, Schwaiger Wolfgang, Grunicke Hans H, Uberall Florian
Institute of Medical Chemistry and Biochemistry, University of Innsbruck, Fritz-Pregistr 3, A-6020 Innsbruck, Austria.
Curr Opin Mol Ther. 2003 Dec;5(6):631-41.
Phorbol esters (PEs) and their derivatives are potent tumor-promoting agents. The best known receptors for these substances are the novel and classical isotypes of protein kinase C (PKC), which bind PE and the physiological second messenger diacylglycerol (DAG) by cysteine-rich domains, the C1 domains. However, PKC is not the sole receptor of PE, a concept that has been largely ignored in the past. PE (in addition to DAG) also targets C1-containing receptors unrelated to PKC. In order to get a better insight into DAG/PE-mediated signaling and the pathways involved, it is necessary to first determine all ligand-interacting proteins. Employing various sources of data, 66 different C1-containing human proteins are presented and predictions of their DAG/PE-binding potential are attempted. Defining the entire set of key mediators for the physiological DAG responses and for PE-induced tumorigenesis may aid our understanding of signal integration and can also help to design new strategies for therapeutic cancer intervention.
佛波酯(PEs)及其衍生物是强效的肿瘤促进剂。这些物质最知名的受体是蛋白激酶C(PKC)的新型和经典同种型,它们通过富含半胱氨酸的结构域即C1结构域结合PE和生理性第二信使二酰基甘油(DAG)。然而,PKC并非PE的唯一受体,这一概念在过去很大程度上被忽视了。PE(除了DAG)还靶向与PKC无关的含C1受体。为了更好地了解DAG/PE介导的信号传导及相关途径,首先有必要确定所有与配体相互作用的蛋白质。利用各种数据来源,列出了66种不同的含C1的人类蛋白质,并尝试预测它们与DAG/PE结合的潜力。确定生理性DAG反应和PE诱导肿瘤发生的全套关键介质,可能有助于我们理解信号整合,也有助于设计新的癌症治疗干预策略。